Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59(®)‐adjuvanted influenza vaccine in older adults: Results from three consecutive seasons

BACKGROUND: In Europe, the enhanced safety surveillance (ESS) of seasonal influenza vaccines is mandatory, in order to detect any potential increase in reactogenicity when the vaccine composition is updated. The MF59(®)‐adjuvanted influenza vaccine (Fluad™) is the first and the only licensed adjuvan...

Descripción completa

Detalles Bibliográficos
Autores principales: Panatto, Donatella, Haag, Mendel, Lai, Piero Luigi, Tomczyk, Sylvie, Amicizia, Daniela, Lino, Maria Maddalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928029/
https://www.ncbi.nlm.nih.gov/pubmed/31617965
http://dx.doi.org/10.1111/irv.12685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928029/
https://www.ncbi.nlm.nih.gov/pubmed/31617965
http://dx.doi.org/10.1111/irv.12685

Ejemplares similares